European Society of Cardiology
Skip navigation links
Home
About the ESC
Membership
Communities
Congresses
Education
Guidelines & Surveys
Journals
Initiatives
Welcome to the European Society of Cardiology. Our mission: to reduce the burden of cardiovascular disease in Europe
 
Heart Failure 2011

Exhibition

Heart Failure Congress 2011

Locate easily the exhibitors by clicking in the Exhibition Floor Plan and learn more about the Heart Failure partners. 
Wisepress Medical Bookshop Oxford University Press SERVIER ZOLL CMS GmbH Philips Healthcare Pfizer Ltd/BMS HeartWare, Inc. C04:12 Alere Pfizer Ltd Boston Scientific Robert Bosch Healthcare GmbH C01:03 Thoratec Corporation Orion Pharma Vifor Pharma Ltd. Medtronic GE Healthcare BRAHMS GmbH Novartis Pharma AG European Society of Cardiology C04:07 6th Asia Pacific Congress of Heart Failure ResMed Europe BG Medicine, Inc. Image Map
 

Exhibitors’ product descriptions:                                     Stand Numbers:

6th Asia Pacific Congress of Heart Failure                               C04:05
1/70-71 Phahonyotin Soi 40
Senanikom
Jatuchak Bangkok
10900 Bangkok
Thailand

Tel: +66 294 024 83
Fax: +66 294 024 84
Email: info@apchf2012.com
Website: www.apchf2012.com

Related conferences: promoting APCHF2012 & APSAVD 2012.

Alere                                                                                         C04:10
Rue des Vignerons 1A
1110 Morges
Switzerland

Tel: +41 804 7140
Fax: +41 218 020 933
Email: carine.isenegger@alere.com
Website: www.alere.com

Alere enables individuals to take charge of improving their health and quality of life at home by developing new capabilities in near-patient diagnosis, monitoring and health management. Our global leading products and services, and new product development efforts, focus on cardiology, women’s health, infectious disease, oncology and drugs of abuse.

BG Medicine, Inc.                                                                      C03:06
610N Lincoln St.
Waltham, MA 02451
United States of America

Tel: +1 781 890 1199
Fax: +1 781 895 1119
Email: communications@bg-medicine.com
Website: www.bgmgalectin-3.com

BG Medicine (NASDAQ:BGMD) is a life sciences company focused on the discovery, development, and commercialization of novel diagnostics to improve patient outcomes and contain healthcare costs.  BG Medicine's Galectin-3 blood test identifies patients with an inherently progressive form of heart failure resulting from fibrogenesis.

Boston Scientific                                                                        C01:06
Le Capitole
55 avenue des Champs Pierreux
TSA 51101
92729 Nanterre Cedex
France

Tel: +33 1 57 66 81 79
Fax: +33 1 57 66 81 72
Email: hadjmims@bsci.com
Website: www.bostonscientific.com

Boston Scientific (NYSE: BSX) is a worldwide developer, manufacturer and marketer of medical devices with approximately 25,000 employees and revenue of $7.806 billion in 2010. For more than 30 years, Boston Scientific has advanced the practice of less-invasive medicine  by providing a broad and deep portfolio of innovative products, technologies and services across a wide range of medical specialties. The Company’s products help physicians and other medical professionals improve their patients’ quality of life by providing alternatives to surgery.  For more information, please visit www.bostonscientific.com.

BRAHMS GmbH                                                                           C03:05
Neuendorfstrasse 25
16761 Hennigsdorf
Germany

Email: info.brahms@thermofisher.com
Website: www.thermofisher.com/brahms

BRAHMS GmbH, Part of Thermo Fisher Scientific, specialises in innovative products which facilitate earlier diagnosis and better control of therapy, thus enabling doctors to provide more efficient and economic patient care.
Major fields of activity are diagnosis of infectious and thyroid diseases, cardiology and pneumology as well as sepsis, tumors, and Down's syndrome.

EUROPEAN SOCIETY OF CARDIOLOGY                                        C03:01
2035 Route Des Colles
Les Templiers - BP 179
06903 Sophia Antipolis
France

Tel: +33 4 92 94 76 00
Fax: +33 4 92 94 86 69
Email: communications@escardio.org
Website: www.escardio.org

The European Society of Cardiology (ESC) represents more than 68,000 cardiology professionals from across Europe and the Mediterranean. The ESC comprises 53 National Cardiac Societies, 19 Working Groups, 5 Associations and 5 Councils. It also includes the distinguished community of ESC Fellows and Nurse Fellows. Its mission is "To reduce the burden of cardiovascular disease in Europe". The ESC achieves this through a series of scientific and educational activities and the ESC Congress, the largest medical meeting in Europe, held this year from 27-31 August 2011 in Paris Nord Villepinte, France.

GE Healthcare                                                                               C03:08
Pollards Wood
Nightingales Lane
Chalfont, St Giles
HP8 4SP Buckinghamshire
United Kingdom

Tel: +44 149 454 4000
Fax: +44 149 449 8234
Email: contactus@ge.com
Website: www.gehealthcare.com

GE Healthcare is dedicated to helping you transform healthcare delivery by driving critical breakthroughs in biology and technology. Our expertise in medical imaging is enabling healthcare professionals around the world discover new ways to diagnose and treat disease earlier. Our goal is more targeted treatments, so they can help their patients live their lives to the fullest.  Please visit our stand while at ESC Heart Failure to learn more about our offerings in cardiology.

HeartWare, Inc.                                                                              C04:11
205 Newbury Street
Framingham, Massachusetts 01701
United States of America

Tel: +1 508 739 0950
Email: l_kryn@yahoo.com
Website: www.heartware.com

HeartWare, Inc. is developing a family of implantable mechanical circulatory support systems for the treatment of advanced heart failure. HeartWare’s lead device, the HeartWare® Ventricular Assist System, incorporates state-of-the-art peripherals and features the only full-output pump designed to be implanted less invasively in the pericardial space. The HeartWare® System is commercially available in Europe and is the subject of a 150-patient US IDE trial.

Medtronic                                                                                        C02:01
Route du Molliau 31
Case postale
1131 Tolochenaz
Switzerland

Tel: +41 218 027 000
Fax: +41 218 027 918
Email: christine.dettwiler@medtronic.com
Website: www.medtronic.eu

At Medtronic, we are committed to "Innovating for life" by pushing the boundaries of medical technology and changing the way the world treats chronic disease.
Join our symposium on May 22, 12:45-14:00 (Malmö), and visit the Medtronic booth (C02:01) to discover how CRT therapy is reducing mortality and preventing disease progression for HF patients.

Novartis Pharma AG                                                                        C04:08
Forum 1
Novartis Campus
4056 Basel
Switzerland

Tel: +41 613 241 111
Email: marco.arnold@novartis.com
Website: www.novartis.com

Novartis provides healthcare solutions that address the evolving needs of patients and societies. Focused solely on healthcare, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, cost-saving generic pharmaceuticals, preventive vaccines, diagnostic tools and consumer health products. Novartis is the only company with leading positions in these areas. In 2010, the Group's continuing operations achieved net sales of USD 50.6 billion, while approximately USD 9.1 billion (USD 8.1 billion excluding impairment and amortization charges) was invested in R&D throughout the Group. Headquartered in Basel, Switzerland, Novartis Group companies employ approximately 119,000 full-time-equivalent associates (including 16,700 Alcon associates) and operate in more than 140 countries around the world. For more information, please visit http://www.novartis.com.

Orion Pharma                                                                                   C01:01
Orionintie 1A
02200 Espoo
Finland

Tel: +35 810 4261
Fax: +35 810 426 3815
Email: firstname.lastname@orionpharma.com
Website: http://www.orion.fi/en/

Orion is an innovative European R&D-based pharmaceuticals and diagnostics company.
Orion Pharma’s critical care product portfolio includes two own proprietary molecules, levosimendan (Simdax®) for acute heart failure and dexmedetomidine for sedation in intensive care.
Simdax®, a cardioprotective inodilator, gives rapid and sustained hemodynamic improvement, normalizes neurohormone levels, and relieves symptoms in patients with acute heart failure.

Oxford University Press                                                                    C01:10
Great Clarendon Street
OX2 6DP Oxford
United Kingdom

Email: jnls.mkt@oxfordjournals.org
Website: www.oup.com

Oxford University Press publishes some of the most respected medical books and journals in the world including The ESC Textbook of Cardiovascular Medicine, and on behalf of the ESC, European Journal of Heart Failure and European Heart Journal. Visit our stand to browse books and pick up free copies of the journals.

Pfizer Ltd                                                                                          C03:10
Pfizer Ltd/BMS                                                                                  C04:15
Walton Oaks
Dorking Road, Tadworth, Surrey
KT20 7NS Tadworth
United Kingdom

Tel: +44 130 461 6161
Email: virginia.hayward@pfizer.com
Website: www.pfizer.co.uk / http://www.bms.com

Pfizer Inc.: Working together for a healthier world™
At Pfizer, we apply science and our global resources to improve health and well-being at every stage of life. We strive to set the standard for quality, safety and value in the discovery, development and manufacturing of medicines for people and animals. Our diversified global health care portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional products and many of the world’s best-known consumer products. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as the world’s leading biopharmaceutical company, we also collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, Pfizer has worked to make a difference for all who rely on us.

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information, please visit http://www.bms.com or follow us on Twitter at http://twitter.com/bmsnews.

Philips Healthcare                                                                            C03:12
Medizin Systeme GmbH
Hewlett-Packard-Str. 2
71034 Boeblingen
Germany

Tel: +49 703 146 329 13
Fax: +49 703 146 322 02
Email: Melanie.Sarantos@philips.com
Website: http://www.healthcare.philips.com/goto/motiva

Motiva – Empower Patients with Long Term Conditions.
Philips Motiva is an interactive healthcare platform that connects patients with chronic conditions, e.g. heart failure, diabetes and COPD, to their healthcare providers – via the home television and a secure network connection.
Motiva automates disease management activities, and engages patients with personalized daily inter-actions and education delivered through the home television. The system enables healthcare providers to motivate behaviour change, helping them meet goals for improved patient compliance, telehealth program efficiency, and lower healthcare costs.

ResMed Europe                                                                                 C04:01
Fjordveien 1
1363 Høvik
Norway

Tel: +47 671 188 50
Fax: +47 671 188 55
Email: post@resmed.no
Website: www.resmed.com

ResMed is a leading developer, manufacturer and marketer of products for the screening, treatment and long-term management of sleep-disordered breathing (SDB) and other respiratory disorders. ResMed is committed to increasing education and awareness by supporting leading physicians and researchers exploring the link between SDB and life-threatening diseases as heart failure, hypertension, and stroke.

Robert Bosch Healthcare GmbH                                                       C01:05
Stuttgarter Straße 130
71301 Waiblingen
Germany

Tel: +49 711 8110
Email: info-bosch-healthcare@bosch.com
Website: www.bosch-telemedizin.de

Bosch Healthcare is presenting an innovative range of products from patients terminals, through fast and secure transmission of vital signs, to comprehensive evaluation software for healthcare professionals. Bosch Telehealth Plus enables interactive monitoring of patients with long-term conditions. The system helps healthcare professionals to identify even gradual changes in a patient´s condition so that treatments can be quickly modified to prevent serious health complications.

SERVIER                                                                                           C02:10
35, rue de Verdun
92284 Suresnes
France

Tel: +33 1 55 72 38 59
Fax: +33 1 55 72 52 95
Email: marie-pascale.eon@fr.netgrs.com
Website: www.servier.com

Servier is a private independent pharmaceutical company.

Servier has developed drugs for the treatment of hypertension, cardiac ischemia, and heart failure. Procoralan (ivabradine), Vastarel MR (trimetazidine), Coversyl (perindopril), Coveram (perindopril-amlodipine), Preterax (perindopril-indapamide), and Natrilix SR (indapamide) are our major cardiovascular drugs.

Procoralan (ivabradine), the first If inhibitor on the market, is indicated for the symptomatic treatment of chronic stable angina. The SHIFT study of the efficacy of Procoralan in the management of heart failure patients was presented at the last ESC congress. Procoralan is now being evaluated by the EMA for approval in this new indication.

Thoratec Corporation                                                                        C01:02
6035 Stoneridge Drive
Pleasanton, CA 94588
United States of America

Tel: +1 925 847 8600
Fax: +1 925 847 8574
Email: sandie.hastings@thoratec.com
Website: www.thoratec.com

Thoratec® Corporation innovates and delivers technologies that enable a full range of therapies to save, support and restore failing hearts, allowing patients to reclaim their lives.  With over 18,000 patient implants and three decades of experience, Thoratec offers the broadest portfolio of ventricular assist devices.  Thoratec's product line includes HeartMateII® LVAD, Thoratec PVAD™ and IVAD™.

Vifor Pharma Ltd.                                                                              C02:02
Flughofstrasse 61
P.O. Box
8152 Glattbrugg
Switzerland

Tel: +41 588 518 000
Fax: +41 588 518 001
Email: info@viforpharma.com
Website: www.viforpharma.com

Vifor Pharma is one of the world leaders in iron preparations for the treatment of iron deficiency and iron deficiency anaemia. Vifor Pharma’s intravenous iron product Ferinject® (ferric carboxymaltose) is expected to address unmet clinical needs and optimise the management of iron deficiency and iron deficiency anaemia.

Wisepress Medical Bookshop                                                            C01:11
25 High Path
Merton Abbey
SW19 2JL London
United Kingdom

Tel: +44 208 715 1812
Email: bookshop@wisepress.com
Website: www.wisepress.com

Wisepress.com, Europe’s leading conference bookseller, has a complete range of books and journals relevant to this meeting including Heart Failure: A Companion to Braunwald's Heart Disease and Hurst’s The Heart. Books can be purchased at the stand or, if you would rather not carry them, posted to you.

ZOLL CMS GmbH                                                                               C03:11
Emil-Hoffmann-Str. 13
50996 Koeln
Germany

Tel: +49 223 687 8725
Fax: +49 223 687 8779
Email: lifevest-deutschland@zoll.com
Website: www.zollmedical.de

The ZOLL® LifeVest® wearable defibrillator protects patients at risk of sudden cardiac arrest, during a patient’s changing condition and when permanent SCA risk has not been established.  The LifeVest provides patients constant monitoring, immediate protection, and peace of mind.



 
Highlight On
All the Heart Failure 2012 congress news from Belgrade
Heart Failure 2012 Late Breaking Trials